EA201401045A1 - Соединения для лечения заболеваний, связанных с ишемией-реперфузией - Google Patents
Соединения для лечения заболеваний, связанных с ишемией-реперфузиейInfo
- Publication number
- EA201401045A1 EA201401045A1 EA201401045A EA201401045A EA201401045A1 EA 201401045 A1 EA201401045 A1 EA 201401045A1 EA 201401045 A EA201401045 A EA 201401045A EA 201401045 A EA201401045 A EA 201401045A EA 201401045 A1 EA201401045 A1 EA 201401045A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- reperfusion
- ischemia
- treatment
- connections
- diseases associated
- Prior art date
Links
- 208000028867 ischemia Diseases 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- External Artificial Organs (AREA)
Abstract
Изобретение относится к соединениям формулы (I), применимым при лечении патологий, связанных с ишемией-реперфузией.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000062A ITFI20120062A1 (it) | 2012-03-21 | 2012-03-21 | Componenti per il trattamento di malattie correlate a ischemia-riperfusione. |
| PCT/IB2013/052205 WO2013140348A1 (en) | 2012-03-21 | 2013-03-20 | Compounds for the treatment of ischemia-reperfusion- related diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201401045A1 true EA201401045A1 (ru) | 2015-03-31 |
| EA033160B1 EA033160B1 (ru) | 2019-09-30 |
Family
ID=46147570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201401045A EA033160B1 (ru) | 2012-03-21 | 2013-03-20 | Соединения для лечения заболеваний, связанных с ишемией-реперфузией |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US9932352B2 (ru) |
| EP (1) | EP2855487B1 (ru) |
| JP (2) | JP6382791B2 (ru) |
| KR (2) | KR20150014910A (ru) |
| CN (1) | CN104395321B (ru) |
| AU (2) | AU2013237021B2 (ru) |
| CA (1) | CA2907652C (ru) |
| CY (1) | CY1118282T1 (ru) |
| DK (1) | DK2855487T3 (ru) |
| EA (1) | EA033160B1 (ru) |
| ES (1) | ES2601384T3 (ru) |
| HR (1) | HRP20161436T1 (ru) |
| HU (1) | HUE031535T2 (ru) |
| IL (1) | IL234796B (ru) |
| IN (1) | IN2014CH07744A (ru) |
| IT (1) | ITFI20120062A1 (ru) |
| LT (1) | LT2855487T (ru) |
| ME (1) | ME02553B (ru) |
| PL (1) | PL2855487T3 (ru) |
| PT (1) | PT2855487T (ru) |
| RS (1) | RS55337B1 (ru) |
| SI (1) | SI2855487T1 (ru) |
| SM (2) | SMT201700055T1 (ru) |
| WO (1) | WO2013140348A1 (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10531655B2 (en) | 2011-12-02 | 2020-01-14 | The Regents Of The University Of California | Reperfusion protection solution and uses thereof |
| IT202000008125A1 (it) * | 2020-04-16 | 2021-10-16 | Minerva Srl | Acidi carbossilici 3-aza-biciclo[3.2.1]ottani e loro derivati per l’uso nel trattamento di infiammazioni |
| IT202200016614A1 (it) | 2022-08-04 | 2024-02-04 | Mimetech S R L | Udonitrectag e sue formulazioni ad uso topico per l’uso nel trattamento di patologie dermatologiche |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR75910B (ru) | 1981-04-21 | 1984-08-02 | Delalande Sa | |
| DE60042585D1 (de) | 2000-02-29 | 2009-09-03 | Univ Firenze | 3-Aza-6,8-dioxabicycloÄ3.2.1Üoctane und Analoga sowie diese enthaltende kombinatorische Bibliotheken |
| ITFI20020107A1 (it) * | 2002-06-19 | 2003-12-19 | Antonio Guarna | Composizioni farmaceutiche atte all'uso nel trattamento di patologie correlate all'azione di neutrofine e composti attivi in esse contenuti |
| AP2005003196A0 (en) * | 2002-07-18 | 2005-03-31 | Pfizer Prod Inc | Bicyclic piperidine derivatives as antagonists of the CCR1 chemokine receptor. |
| WO2006015183A2 (en) * | 2004-07-30 | 2006-02-09 | Axonyx, Inc. | Pharmaceutical compositions for treating disorders of the skin |
| ES2380613T3 (es) * | 2008-11-25 | 2012-05-16 | Universita' Degli Studi Di Firenze | Inhibidores peptidomiméticos bicÃclicos de aspartil-proteasas para el tratamiento de enfermedades infecciosas |
-
2012
- 2012-03-21 IT IT000062A patent/ITFI20120062A1/it unknown
-
2013
- 2013-03-20 LT LTEP13721085.2T patent/LT2855487T/lt unknown
- 2013-03-20 DK DK13721085.2T patent/DK2855487T3/en active
- 2013-03-20 ES ES13721085.2T patent/ES2601384T3/es active Active
- 2013-03-20 HU HUE13721085A patent/HUE031535T2/en unknown
- 2013-03-20 EA EA201401045A patent/EA033160B1/ru unknown
- 2013-03-20 SI SI201330411A patent/SI2855487T1/sl unknown
- 2013-03-20 RS RS20160926A patent/RS55337B1/sr unknown
- 2013-03-20 US US14/387,015 patent/US9932352B2/en active Active
- 2013-03-20 EP EP13721085.2A patent/EP2855487B1/en active Active
- 2013-03-20 SM SM20170055T patent/SMT201700055T1/it unknown
- 2013-03-20 CN CN201380026577.3A patent/CN104395321B/zh active Active
- 2013-03-20 KR KR1020147029365A patent/KR20150014910A/ko not_active Ceased
- 2013-03-20 WO PCT/IB2013/052205 patent/WO2013140348A1/en not_active Ceased
- 2013-03-20 HR HRP20161436TT patent/HRP20161436T1/hr unknown
- 2013-03-20 PL PL13721085T patent/PL2855487T3/pl unknown
- 2013-03-20 AU AU2013237021A patent/AU2013237021B2/en active Active
- 2013-03-20 PT PT137210852T patent/PT2855487T/pt unknown
- 2013-03-20 CA CA2907652A patent/CA2907652C/en active Active
- 2013-03-20 JP JP2015501034A patent/JP6382791B2/ja active Active
- 2013-03-20 KR KR1020207012664A patent/KR102181346B1/ko active Active
- 2013-03-20 ME MEP-2016-251A patent/ME02553B/me unknown
-
2014
- 2014-09-22 IL IL234796A patent/IL234796B/en active IP Right Grant
- 2014-10-21 IN IN7744CH2014 patent/IN2014CH07744A/en unknown
-
2016
- 2016-11-03 CY CY20161101112T patent/CY1118282T1/el unknown
-
2017
- 2017-01-25 SM SM201700055T patent/SMT201700055B/it unknown
- 2017-11-21 AU AU2017265037A patent/AU2017265037B2/en active Active
- 2017-12-12 US US15/839,148 patent/US20180155363A1/en not_active Abandoned
-
2018
- 2018-06-27 JP JP2018122052A patent/JP2018168173A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTC2785706I2 (lt) | Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui | |
| MY170713A (en) | Treatment protocol of diabetes type 2 | |
| UY34820A (es) | Compuestos tipo pirrolo-pirrolidinona | |
| UY33627A (es) | Compuestos para tratar enfermedades neurodegenerativas | |
| UA114087C2 (xx) | Похідні піридину | |
| EA201400178A1 (ru) | Лечение рака молочной железы | |
| EA201401054A1 (ru) | N-циклиламиды в качестве нематоцидов | |
| UY34591A (es) | Compuestos de imidazopirrolidinona | |
| UY34824A (es) | Nucleósidos de espirooxetano de uracilo | |
| UY34523A (es) | Derivados de betulina | |
| CR20150271A (es) | Peptidos como agonistas de oxitocina | |
| UY34582A (es) | Anticuerpos anti-cxcr3 | |
| CR20130539A (es) | Triazolopiridinas | |
| TR201815173T4 (tr) | Peptit bileşimleri. | |
| TR201909923T4 (tr) | Böbrek hastalığının önlenmesi ya da tedavisi için pirazol türevini ihtiva eden kompozisyon. | |
| PH12014502032A1 (en) | Treatment of brain cancer | |
| WO2012104823A3 (en) | Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases | |
| HUS2000037I1 (hu) | Triazinok Protozoa okozta betegségek kezelésére | |
| EA201590503A1 (ru) | Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями | |
| NI201200195A (es) | Procedimiento de preparación de la sal de l - arginina de perindoprilo | |
| NZ720106A (en) | A process for the preparation of regadenoson | |
| MX2015014470A (es) | Analogos de combretastatina. | |
| CR20140531A (es) | Derivados de ariletinilo | |
| CY1119470T1 (el) | Γαλακταγωγες συνθεσεις με βαση φωσφατιδυλοσερινη | |
| IN2013MU01113A (ru) |